Literature DB >> 7559653

The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking.

C García Rodríguez1, D R Cundell, E I Tuomanen, L F Kolakowski, C Gerard, N P Gerard.   

Abstract

Streptococcus pneumoniae has been shown to utilize the platelet activating factor receptor for binding and invasion of host cells (Cundell, D. R., Gerard, N. P., Gerard, C., Idanpaan-Heikkila, I., and Tuomanen, E. I. (1995) Nature, in press). Because bacterial binding is in part carbohydrate dependent, and the human platelet-activating factor (PAF) receptor bears a single N-linked glycosylation sequence in the second extracellular loop, we undertook studies to determine the role of this epitope in PAF receptor function. Binding of pneumococci to COS cells transfected with the human PAF receptor is greatly reduced for a receptor mutant that bears no N-linked glycosylation site. Immunohistochemical and binding analyses show decreased expression of the non-glycosylated molecule on the cell membrane relative to the wild type receptor; however, metabolic labeling and immunopurification indicate it is synthesized intracellularly at a level similar to the native molecule. A mutant receptor encoding a functional glycosylation site at the NH2 terminus is better expressed at the cell surface compared with the non-glycosylated form, indicating that trafficking to the cell surface is facilitated by glycosylation, but its location is relatively unimportant. The binding affinity for PAF is not significantly effected by the presence or location of the carbohydrate, and variations in cell surface expression have little influence on signal transduction, as the non-glycosylated PAF receptor is equally effective for activation of phospholipase C as the native molecule. These data are supportive of pneumococcal binding on protein moiety(ies) of the PAF receptor and indicate that N-glycosylation facilitates expression of the protein on the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559653     DOI: 10.1074/jbc.270.42.25178

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae.

Authors:  Jana N Radin; Carlos J Orihuela; Gopal Murti; Christopher Guglielmo; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.

Authors:  Qiwei Zhang; Nico Mousdicas; Qiaofang Yi; Mohammed Al-Hassani; Steven D Billings; Susan M Perkins; Katherine M Howard; Satoshi Ishii; Takao Shimizu; Jeffrey B Travers
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

3.  N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding.

Authors:  Jiang Jiang; Jianfeng Yang; Ping Feng; Bin Zuo; Ningzheng Dong; Qingyu Wu; Yang He
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

4.  Asn54-linked glycan is critical for functional folding of intercellular adhesion molecule-5.

Authors:  Tomohiro Ohgomori; Tomohisa Nanao; Akinori Morita; Masahiko Ikekita
Journal:  Glycoconj J       Date:  2011-12-21       Impact factor: 2.916

5.  Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor function.

Authors:  Qing Dong; Zhiqiang Cheng; Wenhan Chang; Brigitte E Blackman; Felix A Conte; Jianxin Hu; Dolores Shoback; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

6.  PROCARB: A Database of Known and Modelled Carbohydrate-Binding Protein Structures with Sequence-Based Prediction Tools.

Authors:  Adeel Malik; Ahmad Firoz; Vivekanand Jha; Shandar Ahmad
Journal:  Adv Bioinformatics       Date:  2010-06-29

7.  Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1.

Authors:  Takeshi Harayama; Hideo Shindou; Takao Shimizu
Journal:  J Lipid Res       Date:  2009-04-21       Impact factor: 5.922

8.  Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.

Authors:  Margarita Aponte; Wei Jiang; Montaha Lakkis; Ming-Jiang Li; Dale Edwards; Lina Albitar; Allison Vitonis; Samuel C Mok; Daniel W Cramer; Bin Ye
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

9.  Dissecting Bacterial Cell Wall Entry and Signaling in Eukaryotic Cells: an Actin-Dependent Pathway Parallels Platelet-Activating Factor Receptor-Mediated Endocytosis.

Authors:  Lip Nam Loh; Geli Gao; Elaine I Tuomanen
Journal:  mBio       Date:  2017-01-03       Impact factor: 7.867

10.  Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.

Authors:  Vikrant K Bhosle; José Carlos Rivera; Tianwei Ellen Zhou; Samy Omri; Melanie Sanchez; David Hamel; Tang Zhu; Raphael Rouget; Areej Al Rabea; Xin Hou; Isabelle Lahaie; Alfredo Ribeiro-da-Silva; Sylvain Chemtob
Journal:  Cell Discov       Date:  2016-07-12       Impact factor: 10.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.